Sernova Biotherapeutics Inc Stock
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1200 CAD | +9.09% |
|
+9.09% | -7.69% |
| Market Cap | 45.32M 32.11M 28.23M 26.28M 24.13M 3.08B 45.91M 312M 122M 1.52B 121M 118M 5.26B | P/E 2026 * |
-4x | P/E 2027 * | -3x |
|---|---|---|---|---|---|
| Enterprise Value | 45.32M 32.11M 28.23M 26.28M 24.13M 3.08B 45.91M 312M 122M 1.52B 121M 118M 5.26B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 9.06x |
| Free-Float |
86.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +9.09% | ||
| 1 week | +9.09% | ||
| Current month | -11.11% | ||
| 1 month | -14.29% | ||
| 3 months | -29.41% | ||
| 6 months | -27.27% | ||
| Current year | -7.69% |
| 1 week | 0.11 |  | 0.12 |
| 1 month | 0.1 | | 0.14 |
| Current year | 0.1 | | 0.2 |
| 1 year | 0.1 | | 0.21 |
| 3 years | 0.1 | | 0.92 |
| 5 years | 0.1 | | 2.22 |
| 10 years | 0.1 | | 2.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Rigby
CEO | Chief Executive Officer | 58 | 12/08/2024 |
James Parsons
DFI | Director of Finance/CFO | 60 | 11/10/2024 |
David Burke
IRC | Investor Relations Contact | - | 11/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Tanya Lewis
BRD | Director/Board Member | 55 | - |
John Brooks
CHM | Chairman | 75 | 23/09/2025 |
James Parsons
BRD | Director/Board Member | 60 | 19/04/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03/07/26 | Sell | Company | -115,000 | 0.0305% | ||
| 22/05/26 | Option | Chairman | 228,912 | 0.0658% | ||
| 22/05/26 | Option | Director | 166,482 | 0.0479% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.09% | +9.09% | -41.46% | -87.23% | 32.11M | |
| +1.97% | +5.51% | -16.55% | +19.41% | 129B | |
| +0.39% | +3.60% | -0.51% | -1.98% | 13.01B | |
| -1.09% | -2.28% | +61.09% | +95.26% | 8.92B | |
| +5.94% | +2.18% | -45.47% | -69.36% | 4.65B | |
| +0.75% | -.--% | -.--% | +33.92% | 3.63B | |
| +2.16% | -1.57% | +0.47% | +40.11% | 2.68B | |
| +1.49% | -2.72% | -19.16% | -26.12% | 1.61B | |
| +3.09% | -0.25% | -25.21% | -33.80% | 1.63B | |
| +4.51% | +5.25% | +2.58% | -55.84% | 1.63B | |
| Average | +2.83% | +2.18% | -8.42% | -8.56% | 16.69B | |
| Weighted average by Cap. | +1.80% | +2.73% | -11.25% | +18.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 5M 3.54M 3.11M 2.9M 2.66M 340M 5.07M 34.46M 13.46M 168M 13.3M 13.01M 580M |
| Net income | -12.83M -9.09M -7.99M -7.44M -6.83M -872M -13M -88.41M -34.53M -430M -34.12M -33.39M -1.49B | -19.77M -14.01M -12.32M -11.47M -10.53M -1.34B -20.03M -136M -53.23M -663M -52.6M -51.46M -2.29B |
| Net Debt | - | - |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/07/26 | CA$0.1200 | +9.09% | 48,740 |
| 24/07/26 | CA$0.1100 | -8.33% | 5,706 |
| 23/07/26 | CA$0.1200 | 0.00% | 36,729 |
| 22/07/26 | CA$0.1200 | +9.09% | 41,163 |
| 21/07/26 | CA$0.1100 | 0.00% | 34,582 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1200CAD
Average target price
0.4500CAD
Spread / Average Target
+275.00%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SVA Stock
Select your edition
All financial news and data tailored to specific country editions
